; (2) for a cosmetic ingredient exempt from public disclosure under section 720.8 of title 21, Code of Federal Regulations (as in effect on the date of enactment of the Cosmetic Modernization Amendments of 2017 and including any successor regulations); or (3) by an entity to the extent such entity is exempted by section 605(e) from registration under section 605. . 6. Serious and unexpected adverse event reporting for cosmetics (a) In general Chapter VI ( 21 U.S.C. 361 et seq.), as amended by sections 3, 4, and 5, is further amended by adding at the end the following: 607. Serious and unexpected adverse event reporting for cosmetics (a) In general The Secretary shall by regulation require that a domestic or foreign manufacturer, packer, or distributor whose name appears on the label pursuant to section 602(b)(1) of a cosmetic marketed in the United States submit to the Secretary under subsection (b) a report containing— (1) information received concerning any serious and unexpected adverse event in the United States allegedly associated with the use of the cosmetic for which it is reasonably likely that the adverse event was caused by the cosmetic when used as recommended or suggested in the labeling; and (2) a copy of the label for the cosmetic. (b) Submission of reports A report on an adverse event under subsection (a) shall be submitted to the Secretary not later than 15 business days after information concerning the adverse event is received at the place of business labeled on the cosmetic pursuant to section 602(b)(1). (c) Required contents A report under subsection (a) shall include all of the following information: (1) An identifiable patient. (2) An identifiable reporter. (3) A suspect cosmetic or component thereof. (4) A serious adverse event. (d) Additional contents; supplemental reporting The person submitting a report under subsection (a) may— (1) include pertinent information in addition to the information listed in subsection (c)